By Paige Zimmer, Founder & Principal Advisor, Zimmer Advisor
If you're responsible for your organization's employee health benefits, the new pharmacy benefit manager (PBM) disclosure rule creates a timely opportunity to ask better questions about pharmacy costs before your next renewal.
The Department of Labor published its final PBM fee disclosure rule in the Federal Register on November 2, 2026. Its requirements apply to plan years beginning on or after July 1, 2027. For many employers, that leaves only months to prepare for a renewal conversation that could shape the next plan year.
Much of the coverage will explain the regulation line by line. That matters. This guide focuses on what employers can do with greater visibility: identify the questions they need answered, compare options on their own plan data, and connect pharmacy spending decisions to the employee experience.
A new rule does not automatically lower costs. It can give plan fiduciaries better information to evaluate fees, compensation and service arrangements, and to make more informed decisions.
For years, employers have asked for a clearer view of pharmacy spending: what the plan paid, what the pharmacy received, and how fees, rebates and other payments affect the total. Better visibility can support sharper renewal questions and a more grounded discussion about cost, access and member experience.
Turn transparency into renewal questions
Employers can use pharmacy data to examine both the financial arrangement and how the benefit works for members. Some partners help plans obtain and interpret claims and pricing data. Others use the findings to inform benefit design or help people navigate prescriptions.
For example, an employee might receive a text showing an expected prescription cost before going to the pharmacy. Changes like this may be available through partners working alongside an employer's existing broker, consultant or administrator. Evaluate each option against your plan's needs and data.
Use these questions to guide a discussion with your current partners or evaluate alternatives:
· Pass-through pharmacy benefits. For small and midsize self-funded and level-funded employers, a pass-through PBM shows what it paid the pharmacy, charges one flat administrative fee, adds no spread and credits the plan with every manufacturer rebate it receives. Ask for a comparison built on your own claims, and how a switch would affect employees' pharmacies and medications.
· Configurable claims administration. A pharmacy benefit administration platform processes claims in real time using your plan's own rules for coverage and cost sharing, giving you more control over benefit design and direct access to claims data. Ask which pharmacy network and formulary options come with it.
· Rebate contracting and oversight. A partner that handles manufacturer contracting, formulary strategy and rebate administration lets you evaluate those services separately from your PBM. Ask how rebates are tracked and reconciled, and compare total drug cost after rebates, fees and member cost sharing.
· Medical expense reimbursement. A reimbursement arrangement can help eligible employees with the cost of enrolling in a spouse's employer-sponsored plan. Ask the partner to model who would qualify and what it would cost after reimbursements and fees.
· Medication selection informed by genetics. Pharmacogenomics gives clinicians another input when choosing certain medications. Ask which drugs the program covers, how clinicians use the results, and how it measures changes in prescribing and spending.
· Prescription discount card programs. These give employees another price to compare with their copay or the pharmacy's cash price. Ask partners to price the same drug, strength and quantity at the pharmacies your employees use, and remind employees to check whether discount card purchases count toward their deductible.
· Personalized pharmacy guidance by text. Health technology companies can text employees and covered family members guidance tailored to their prescriptions and coverage: what's covered, what they'll likely pay and whom to call when a prescription needs prior authorization. Ask how it personalizes guidance for each family member and when it hands off to a pharmacist or benefits specialist.
· Support that gets prescriptions filled. Prior authorization help, patient education and refill outreach remove the barriers that delay treatment. Ask how the partner tracks time to fill any unresolved cases.
Key dates for employers
· July 1, 2027: The Department of Labor's final rule requires PBMs and certain affiliated brokers and consultants to disclose how they're paid to large self-insured plans, generally those with 100 or more participants, starting with plan years that begin on or after this date. (DOL final rule)
· August 3, 2028: The Consolidated Appropriations Act of 2026 adds PBM reporting and 100% rebate pass-through requirements for plan years beginning on or after this date, which means January 1, 2029, for calendar-year plans. (2026 Consolidated Appropriations Act)
If your renewal is in the next year, begin the discussion early. Ask what data will be available, who will review it, and how the findings will inform decisions before your contract is finalized.
Start with your renewal
What would you most like to understand or improve about your pharmacy benefit before the next renewal?
You may be trying to explain rising pharmacy spend, improve employees' ability to understand prescription costs, or get a second perspective on the choices in front of you.
I help employers clarify the problem, evaluate relevant options and connect with partners when a fit makes sense. To start a useful conversation, share your renewal month, the pharmacy benefit question you are trying to answer, and whether your priority is cost, data visibility or the member experience.
Ready to discuss your renewal? Contact Paige Zimmer through Zimmer Advisor to start the conversation.
Disclosure: I have advisory or business relationships with some of the types of organizations described above. I may make introductions where relevant; employers should evaluate any provider and recommendation based on their own needs.